Error: Could not add to watchlist. X

Santarus Inc

+ Watchlist
SNTS:US
Acquired
SNTS:US was acquired by VRX:CN
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
2.36
Market Cap (USD)
-
Shares Outstanding (m)
67.129
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Santarus, Inc. focuses on acquiring, developing, and commercializing proprietary products. The Company offers budesonide, bromocriptine mesylate, fenofibrate, omeprazole, and metformin hydrochloride extended release tablets. Santarus operates in the State of California.
ADDRESS
12230 El Camino Real
Suite 300
San Diego, CA 92130
United States
PHONE
1-858-314-5700
WEBSITE
-
  • Timothy J Creech "Tim"
    President
  • Teri L Chuppe
    VP/Controller
  • Jonathan M Hee
    VP:Commercial Affairs
  • Martha L Hough
    VP:Finance
  • Thomas J Joyce
    VP:Mktg & Natl Accounts
Show More